Advertisement

European Journal of Nuclear Medicine

, Volume 17, Issue 1–2, pp 69–76 | Cite as

In vitro validation of a simple tomographic technique for estimation of percentage myocardium at risk using methoxyisobutyl isonitrile technetium 99m (sestamibi)

  • Michael K. O'Connor
  • Thomas Hammell
  • Raymond J. Gibbons
Original article

Abstract

With the advent of technetium 99m-labeled myocardial blood flow agents, there is a need for a simple technique for quantitation of infarcted or jeopardized myocardium (IM). This study provides an in vitro validation of a simple technique based upon the analysis of three short-axis slices through the heart following emission computed tomography. All acquisitions were performed using a static cardiac phantom containing pertechnetate Tc 99 m. Activity in the phantom was adjusted so that the count density and myocardial-to-background ratio were comparable to those observed in patients. Plastic insets (range of sizes = 4%–72% of myocardium) were used to simulate transmural infarctions. Eighteen studies were acquired, each over 180° into a 64 × 64 matrix. Data were reconstructed using a Ramp Hanning filter with cut off at 0.7 times the Nyquist frequency. Short-axis slices of the myocardium were then generated, and representative apical (A), mid-ventricular (MV), and basal (B) slices were selected. For each slice, a circumferential profile was generated, and the average radius (R) was measured. The fraction (F) of the profile falling below a threshold value was considered to represent IM. Total IM was given by %IM =100 x (RBFB +RMVFMV + 0.67RAFA)/(RB +RMV + 0.67RA), where the subscripts to R and F refer to the relevant short-axis slices. For a threshold set at 60% of peak, measured IM agreed closely with true IM (R2=0.98, measured IM =1.01 x true IM −1.35). Measurement of % IM was not distorted by variations in slice radius or in slice selection. Maximum error in % IM occurred with a change in location of the infarct (approximately 4% for opposing walls). This technique permits rapid and accurate assessment of % IM with99mTc-labeled myocardial blood flow agents.

Key words

SPET Infarct size Cardiac phantom 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anger HO (1967) Radioisotope cameras. In: Hine GJ (ed) Instrumentation in nuclear medicine. Academic Press, New York, pp 485–552Google Scholar
  2. Budinger TF, Rollo FD (1977) Physics and instrumentation. Prog Cardiovasc Dis 20:19–53Google Scholar
  3. Caldwell JH, Williams DL, Harp GD, Stratton JR, Ritchie JL (1984) Quantitation of size of relative myocardial perfusion defect by single photon emission computed tomography. Circulation 70:1048–1056Google Scholar
  4. DeCoster PM, Melvin JA, Detry J, Brasseur LA, Beckers C, Col J (1985) Coronary artery reperfusion in acute myocardial infarction: assessment by pre- and post-intervention thallium-201 myocardial perfusion imaging. Am J Cardiol 55:889–895Google Scholar
  5. Feiring AS, Johnson MR, Kioschos JM, Kirchner PT, Marcus ML, White CW (1987) The importance of the determination of the myocardial area at risk in the evaluation of the outcome of acute myocardial infarction in patients. Circulation 75:980–987Google Scholar
  6. Gibbons RJ, Verani MS, Behrenbeck T, Pellikka PA, O'Connor MK, Mahmarian JJ, Wackers FJ (1989) Feasibility of technetium-99m-hexakis-2-methoxypropyl-isonitrile for the assessment of myocardial perfusion during and after acute myocardial infarction. Circulation 80:1277–1286Google Scholar
  7. Granato JE, Watson DD, Flanagan TL, Gascho JA, Beller GA (1986) Myocardial thallium-201 kinetics during coronary occlusion and reperfusion: influence of method of reflow and timing of thallium-201 administration. Circulation 73:150–160Google Scholar
  8. Holman BL, Moore SC, Shulkin PM, Kirsch CM, English RJ, Hill TC (1983) Quantitation of perfused myocardial mass using T1-201 and emission computed tomography. Invest Radiol 18:322–326Google Scholar
  9. Johnson LL, Lerrick KS, Coromilas J, Seldin DW, Esser PD, Zimmerman JM, Keller AM, Alderson PO, Bigger JT, Cannon PJ (1987) Measurement of infarct size and percentage myocardium infarcted in a dog preparation with single photon emission computed tomography, thallium-201, and indium 111-monoclonal antimyosin Fab. Circulation 76:181–190Google Scholar
  10. Keyes JW, Brady TJ, Leonard PF, Svetkoff DB, Winter SM, Rogers WL, Rose EA (1981) Calculation of viable and infarcted myocardial mass from thallium-201 tomograms. J Nucl Med 22:339–343Google Scholar
  11. Li QS, Frank TL, Franceschi D, Wagner HN, Becker LC (1988) Technetium-99m methoxyisobutyl isonitrile (RP 30) for quantification of myocardial ischemia and reperfusion in dogs. J Nucl Med 29:1539–1548Google Scholar
  12. Narahara KA, Thompson CJ, Maublant CJ, Criley JM, Mena I (1987) Estimation of left ventricular mass in normal and infarcted canine hearts using thallium-201 SPET. J Nucl Med 28:1315–1321Google Scholar
  13. Okada RD, Pohost GM (1984) The use of pre-intervention and post-intervention thallium imaging for assessing the early and late effects of experimental coronary arterial reperfusion in dogs. Circulation 69:1153–1160Google Scholar
  14. Okada RD, Glover D, Gaffney T, Williams S (1988) Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. Circulation 77:491–498Google Scholar
  15. Prigent F, Maddahi J, Garcia EV, Satoh Y, Van Train K, Berman DS (1986) Quantification of myocardial infarct size by thallium-201 single photon emission computed tomography: experimental validation in the dog. Circulation 74:852–861Google Scholar
  16. Ritchie JL, Davis KB, Williams DL, Caldwell J, Kennedy JW (1984) Global and regional left ventricular function and tomographic radionuclide perfusion: the Western Washington Intracoronary Streptokinase in Myocardial Infarction Trial. Circulation 70:867–875Google Scholar
  17. Schneider RM, Chu A, Akaishi M, Weintramb W, Morris K, Cobb F (1985) Left ventricular ejection fraction after acute coronary artery occlusion in dogs: relationship to the extent and site of myocardial infarction. Circulation 72:632–638Google Scholar
  18. Sorensen JA, Phelps ME (1987) Physics in nuclear medicine. Grune and Stratton, New York, pp 221–229Google Scholar
  19. Tamaki S, Nakajima H, Murakami T, Yui Y, Kambara H, Kadota K, Yoshida A, Kawai C, Tamaki N, Mukai T, Ishii Y, Torizuka K (1982) Estimation of infarct size by myocardial emission computed tomography with thallium-201 and its relation to creatinine kinase-MB release after myocardial infarction in man. Circulation 66:994–1001Google Scholar
  20. Wackers FJ, Berman DS, Maddahi J, Watson DD, Beller GA, Strauss HW, Boucher CA, Picard M, Holman BL, Fridrich R, Inglese E, Delaloye B, Bischof-Delaloye A, Camin L, McKusick K (1989) Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 30:301–311Google Scholar
  21. Weiss RJ, Buda AJ, Pasyk S, O'Neill WW, Keyes JW, Pitt B (1983) Noninvasive quantification of jeopardized myocardial mass in dogs using 2-dimensional echocardiography and thallium-201 tomography. Am J Cardiol 52:1340–1344Google Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • Michael K. O'Connor
    • 1
  • Thomas Hammell
    • 1
  • Raymond J. Gibbons
    • 1
  1. 1.Department of Diagnostic Radiology and Division of Cardiovascular Diseases and Internal MedicineMayo ClinicRochesterUSA

Personalised recommendations